Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
2024年2月20日 - 11:00PM
Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation
and the originator of medical-grade skincare, is thrilled to
announce the appointment of Dr. Suzan Obagi as the Company’s
first-ever Chief Medical Director. Obagi is a subsidiary of
Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand
beauty and wellness platform and publicly listed company. Dr. Obagi
brings a wealth of experience and expertise to her role, further
solidifying Obagi's commitment to providing advanced,
transformative skincare solutions.
Dr. Suzan Obagi is a world-renowned, leading board-certified
dermatologist and cosmetic surgeon, recognized for her
groundbreaking contributions to the fields of dermatology, cosmetic
surgery, and skincare. Throughout her illustrious career, Dr. Obagi
has become a top authority in aesthetic dermatology, medical-grade
skincare, anti-aging treatments, and skin health, focusing her
practice across a wide range of skin types, including darker skin.
In addition to her practice, Dr. Obagi has trained physicians from
around the world on the latest advancements in cosmetic and laser
surgery; authored articles and book chapters on skin health
restoration, autologous fat augmentation, Botox and soft tissue
fillers, chemical peeling, dermabrasion, and lasers; and lectured
to medical specialists and surgeons across a variety of specialties
including ophthalmologic, facial plastic, cosmetic, oral and
maxillofacial and dermatological on many of these topics.
In her role of Chief Medical Director, Dr. Obagi will play a
pivotal role in shaping Obagi's product development, portfolio
refinement, research initiatives, and educational programs to
ensure Obagi continues to provide the gold standard for skincare to
the physician-dispensed market. Her extensive knowledge of
dermatology and aesthetic medicine, as well as her commitment to
evidence-based practices, will contribute to the continued growth
and success of Obagi as a global skincare leader.
“I am thrilled to be taking on a more formal role at Obagi as
the Company’s first-ever Chief Medical Director,” said Dr. Suzan
Obagi. “Obagi has an incredible reputation for delivering
high-quality, medical-grade skincare solutions. In this new
position, I am looking forward to impacting upstream product
development to deliver new innovations that solve more skin
concerns for more patients and consumers, as well as educating the
professional community on Obagi’s transformational, science-backed
skincare solutions.”
As a pioneer in the skincare industry, Obagi is known for its
targeted medical-grade solutions that provide transformative
results. For example, its Obagi Nu-Derm® System, Professional-C®,
ELASTIderm®, and Obagi Nu-Cil™ product portfolios treat common skin
concerns, including hyperpigmentation, fine lines and wrinkles,
hydration, brightening skin, and acne. Dr. Obagi's appointment
reflects Obagi's dedication to staying at the forefront of
scientific advancements in skincare and delivering unparalleled
results through innovative products to its diverse customers.
"We are honored to deepen our relationship with Dr. Suzan Obagi
as she assumes the role of Obagi’s inaugural Chief Medical
Director," said Jordan Meyer, President of Obagi. "Dr. Obagi has
been connected to our brand, in various capacities, since its
inception.” Meyer added, “Her deep understanding of dermatology,
commitment to patient care, and passion for advancing skincare
reflect Obagi’s expertise and legacy in providing science-backed,
physician-dispensed skincare solutions that empower individuals to
achieve healthy, beautiful skin. We look forward to the positive
impact her expertise will have on our team, products, and the
overall skincare experience for our customers."
About Obagi Cosmeceuticals Obagi Cosmeceuticals
is an industry-leading, advanced skincare line rooted in research
and skin biology, refined with a legacy of 30 years’ experience.
First known as leaders in the treatment of hyperpigmentation with
the Obagi Nu-Derm® System, Obagi products are designed to diminish
the appearance of premature aging, photodamage, skin discoloration,
acne, and sun damage. Backed by science and trusted by
professionals, Obagi empowers individuals to achieve healthy,
beautiful skin.More information about Obagi is available on the
brand’s website, https://www.obagi.com.
About WaldencastFounded by Michel Brousset and
Hind Sebti, Waldencast’s ambition is to build a global
best-in-class beauty and wellness operating platform by developing,
acquiring, accelerating, and scaling conscious, high-growth
purpose-driven brands. Waldencast’s vision is fundamentally
underpinned by its brand-led business model that ensures proximity
to its customers, business agility, and market responsiveness,
while maintaining each brand’s distinct DNA. The first step in
realizing its vision was the business combination with Obagi
Cosmeceuticals and Milk Makeup. As part of the Waldencast platform,
its brands will benefit from the operational scale of a multi-brand
platform; the expertise in managing global beauty brands at scale;
a balanced portfolio to mitigate category fluctuations; asset-light
efficiency; and the market responsiveness and speed of
entrepreneurial indie brands. For more information please visit:
https://ir.waldencast.com/.
About Suzan Obagi, MDSuzan Obagi, MD Obagi is
an Associate Professor of Dermatology and Plastic Surgery at the
University of Pittsburgh Medical Center (UPMC) and serves as the
director of the state-of-the-art UPMC Cosmetic Surgery and Skin
Health Center. Dr. Obagi's academic commitments include
clinical research, training residents in dermatologic surgery &
cosmetic dermatologic surgery, and in her role as the director of
the cosmetic dermatologic surgery fellowship.
Dr. Obagi has worked on various committees with the American
Society for Dermatologic Surgery, has formerly served as vice
president of the American Board of Cosmetic Surgery and the
President of the American Academy of Cosmetic Surgery, and is a
past president of the Cosmetic Surgery Foundation. In
addition, Dr. Obagi trains physicians from around the world on the
latest in cosmetic and laser surgery.
Media Contact:Sarah Montalto Managing Director,
ICRobagi@icrinc.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/a110ce38-015f-4b19-a397-7661f34e7953
Waldencast (NASDAQ:WALD)
過去 株価チャート
から 8 2024 まで 9 2024
Waldencast (NASDAQ:WALD)
過去 株価チャート
から 9 2023 まで 9 2024